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Introduction 
The symptoms of high fever and cough were recognised in Wuhan City (China) 
in December 2019 and were identified as caused by the novel coronavirus SARS-
CoV-2. In 2020, the World Health Organization (WHO) declared COVID-19 
to be a pandemic and recommended many precautionary measures to counter 
the disease. According to WHO in November 2020 the number of confirmed 
cases worldwide was 54,400,000 and deaths 1,320,000. The threat to health 
services is immense and is exemplified by the experience in Italy where services 
struggled to cope.[1]
Unusual clinical presentations, other than those related to the respiratory 
system, of COVID-19 challenges the skills of the healthcare professional. These 
presenting features may be related to almost any system of the human body.[2] In 
this review we describe this wide variety of presentations system by system with 
the aim of alerting clinicians of these important factors. 
Central nervous system (CNS) and psychiatry
Neurological symptoms may be manifestations of the COVID-19. In one report, 
a 35-year-old female complained of a severe occipital headache radiating to the 
neck and accompanied by convulsions. After T2 Fluid-attenuated inversion 
recovery magnetic resonance imaging had been carried out, the initial diagnosis 
was as a glioma, then surgically treated after the failure of anti-epileptic drugs. 
A left anterior temporal lobectomy was performed, without postoperative 
complications. The histological study proved it was a case of encephalitis. Also, 
the result of PCR for COVID-19 was positive. Other symptoms may suggest a 
stroke.[3,4]
A relapse of a pre-existing disease may occur as in a reported case of myasthenia 
gravis where the patient suffered from dysphagia, exacerbated ptosis and with 
respiratory symptoms like exertional dyspnoea.[5]
Psychological and psychiatric symptoms may also result from COVID-19: 
depression, insomnia, memory problems, delirium, psychosis and mania have 
been recorded.[6]  A case of Guillain Barré syndrome associated with COVID-19 
infection was reported by Sedaghat and Karimi.[7]
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Abstract
The coronavirus pandemic (COVID-19) has placed enormous challenges 
on the health sector. Diagnosis is one of these challenges, where a clinical 
presentation may suggest a disease other than COVID-19. In this review we 
describe many presentations unrelated to the respiratory system. The ACE2 
receptor is present in a wide variety of body tissues and it appears that this may 
be a link with the clinical pathology. To find these data we searched the major 
academic research engines, Google Scholar, and Pubmed, as well as the most 
recent case reports and original research published in specialized journals.
An awareness of these uncommon presentations helps health workers to 
recognize and treat the disease early and appropriately.
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Special senses
Loss of the sense of smell and taste are early symptoms of 
COVID-19. Based on a study involving 141 patients in 
Qatar the prevalence was 11.35%, 4.96%, and 8.51% of 
ageusia, anosmia or both respectively. It is likely that the 
mechanism is not related to nasal congestion or rhinitis, 
but chemosensory dysfunction.[8,9]
COVID-19 can affect the eyes. A case has been reported 
of redness and pain in the right eye with watery discharge. 
Nasopharyngeal and eye swabs were positive for corona 
virus, and the final diagnosis was keratoconjunctivitis due 
to COVID-19.[10] We have  not found a significant case 
of COVID-19 with hearing involvement.
Cardiovascular system
COVID-19 may affect the cardiovascular system. A male 
patient complained of sticky sputum and dyspnoea on 
effort. He had elevated cardiac and inflammatory markers, 
sinus tachycardia and ST segment elevation on ECG. 
Transthoracic echocardiography revealed “severe global 
left ventricular systolic dysfunction, right ventricular 
(RV) enlargement, RV systolic dysfunction. A moderate-
to-large pericardial effusion was noted anterior to the RV 
with organizing material”.[11]
Gastrointestinal tract
Many COVID-19 patients have diarrhoea, vomiting or 
abdominal pain sometimes preceded by fever, cough and 
chest pain.[12] Haemorrhagic colitis, peritonitis and an 
acute hepatitis-like syndrome have been reported.[13-15]
Renal manifestations
Acute kidney injury has been noted. Renal biopsy has 
shown focal segmental glomerulosclerosis (FSGS) and 
acute tubular damage.[16] According to one study 75.4% of 
the hospitalized cases with SARS-CoV-2 had haematuria, 
proteinuria or acute kidney injury.[17]
Dermatological features
Dermatologists analyzed data of confirmed COVID-19 
cases and found 18 with skin eruption. Eight of them 
showed skin symptoms from the beginning, while the 
rest showed them after hospital admission. These features 
included erythematous rash, an eruption resembling 
chickenpox and urticaria. The distribution was mostly in 
the central region, and itching was the most prominent 
symptom.[18]
There is a case report of a patient with an itchy, 
erythematous rash and yellowish papules on the heels 
with itchy erythematous plaques all over the face and 
peripheries and diffuse joint pains without swelling.[19]
Discussion
Studies suggest that ACE2 receptors may be involved 
with the access of SARS-CoV-2 into body tissues.[20]
The virus has been found in brain tissue and cerebrospinal 
fluid and hence it is not surprising to observe psychological 
and neurological symptoms.[20]
ACE2 receptors are found in the nasal mucosa and so may 
mediate the mechanism for anosmia via bradykinin and 
other inflammatory proteins.[21] The olfactory pathway 
is within the central nervous system so coronavirus may 
directly harm one of the structures of that pathway e.g., 
olfactory bulb. 
This coronavirus induces a cytokine storm, the most 
prominent involving interleukin-6, which can harm 
neurons.[22]
ACE2 receptors are present in specialized cells in the 
glossal taste buds and hence may play a key role in 
changing the taste sensation.
The taste buds have receptors for sialic acid which protect 
glycoprotein molecules from enzyme degradation. The 
coronavirus has the ability to compete with that acid and 
link to those receptors with loss of taste.[23]
ACE2 receptors are widespread and much more work is 
needed to understand their significance and mechanism 
in relation to coronavirus infection and the clinical 
pathology. 
Conclusion
It is essential that those caring for COVID-19 patients 
are aware of clinical signs and symptoms that mimic 
other disease processes. Lack of such awareness has serious 
implications for the management of patients who are not 
at first suspected as having the coronavirus infection and 
for the wider spread of the virus. 
This review provides a resource for healthcare professionals 
alerting them to these unusual presentations and so 
enhancing patient care and reduction of virus spread. Our 
knowledge about COVID-19 is progressing rapidly and 
it is difficult to keep up with the pace of publications. 
This review is therefore unlikely to be complete but it is 
intended to be an alert. It shows that there is still much 
more to learn.
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